Croda International Plc (LON:CRDA – Get Free Report)’s share price reached a new 52-week low during trading on Wednesday after Deutsche Bank Aktiengesellschaft lowered their price target on the stock from GBX 3,400 to GBX 3,000. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock. Croda International traded as low as GBX 2,545 ($33.74) and last traded at GBX 2,554 ($33.86), with a volume of 4746777 shares traded. The stock had previously closed at GBX 2,598 ($34.45).
Other equities analysts also recently issued research reports about the company. Citigroup cut their target price on Croda International from GBX 3,550 ($47.07) to GBX 3,300 ($43.75) and set a “neutral” rating for the company in a research report on Tuesday, April 29th. Berenberg Bank cut their target price on Croda International from GBX 3,800 ($50.38) to GBX 3,100 ($41.10) and set a “buy” rating for the company in a research report on Tuesday. Finally, JPMorgan Chase & Co. upgraded Croda International to an “overweight” rating in a research report on Wednesday.
View Our Latest Stock Report on CRDA
Insider Buying and Selling
Croda International Stock Up 0.1%
The company has a quick ratio of 2.25, a current ratio of 2.72 and a debt-to-equity ratio of 30.90. The firm has a 50 day simple moving average of GBX 2,985.88 and a 200-day simple moving average of GBX 3,033.44. The stock has a market cap of £3.64 billion, a P/E ratio of 22.35, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74.
Croda International (LON:CRDA – Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported GBX 72.20 ($0.96) earnings per share (EPS) for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. On average, equities research analysts forecast that Croda International Plc will post 181.8307268 earnings per share for the current fiscal year.
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Recommended Stories
- Five stocks we like better than Croda International
- How to Calculate Stock Profit
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
- Options Trading – Understanding Strike Price
- How Marvell Went From Short Target to Breakout Star
- What is MarketRank™? How to Use it
- Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.